\
Study Group Alegent Creighton Health Research Center (Ref number:171)
Description Grand 306
Study Number Grand 306
Disease Site Pancreas
Condition Type 2 Diabetes
Phone Number 402-343-8511
Contact Name Sharon Whitman
Additional Information A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate Cardiovascular Outcomes of TAK-875, 50 mg in Addition to Standard of Care in Subjects with Type 2 Diabetes and with Cardiovascular Disease or Multiple Risk Factors for Cardiovascular Events